William Ringo
Senior Vice President, Strategy and Business Development, Pfizer Inc
Bill Ringo is the Senior Vice President of Strategy and Business Development at Pfizer, with responsibility for guiding the company's overall strategic planning and business development activities.
Prior to joining Pfizer in April 2008, Bill served as an executive in residence at Warburg Pincus and Sofinnova Ventures. From 2004 to 2006, he was President and CEO of Abgenix, Inc., a biotechnology firm focused on developing human antibodies as agents to treat cancer and other serious diseases. At Abgenix, he led efforts to transform the organization into a more focused product company by strengthening the senior management team and enhancing an existing partnership with Amgen, which purchased Abgenix in 2006.
From 2001 to 2004, he served on various boards - including the board of Encysive Pharmaceuticals, which Pfizer recently acquired – and was associated with Intermune, where he was appointed interim chief executive officer to help restructure the company and recruit new operational leadership.
Bill began his career at Eli Lilly & Company in 1973 and during his 28-year tenure there he held a number of senior positions, including Product Group President for Oncology and Critical Care, President of Internal Medicine Products, President of the Infectious Diseases Business Unit, and Vice President of Sales and Marketing for U.S. Pharmaceuticals. He retired from Lilly in 2001.
Bill - who holds a B.S. in Business Administration and an M.B.A. form the University of Dayton - serves on the Board of Directors of BioCrossroads, a public-private collaboration of corporate, university, government and entrepreneurial leaders that supports Indiana's life sciences research and corporate strengths in life sciences while encouraging business development in the region.
Find out more about Pfizer career opportunities, search for current open positions, and submit your resumé online.
Learn more about our progress in building a foundation for solid, sustainable growth and
our promise to continue
as a leader in meeting
one of the world's most basic needs: better health care for more people.

